Australia’s Healius on Tuesday said private equity firm Partners had offered to acquire the medical center operator for A$2.12 billion ($1.40 billion).
The Swiss private equity firm offered A$3.40 per share in cash, a 23.2% premium to Healius’ last closing price.
A filing earlier in the day showed Partners bought out China’s Jangh’s 15.9% majority stake in Healius.
Jangho had previously offered to buyout Healius for A$1.7 billion or A$3.25 per share, which was rejected by the Sydney-based company, saying it was “opportunistic” and fundamentally undervalued the company.
The company said it has not yet formed a view on Partners’ offer, adding that it was also subject to six weeks of due diligence.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Urged to Enforce Rarely Used Antitrust Law Against Retail Giants
Mar 28, 2024 by
CPI
UK’s Fingleton Bolsters Team with New Additions
Mar 28, 2024 by
CPI
Britain’s Competition Regulator Clears Aviva’s Acquisition of AIG Life UK
Mar 28, 2024 by
CPI
White House Implements New AI Safeguards to Protect Rights and Safety
Mar 28, 2024 by
CPI
Denver Court Sets August Date for Kroger-Albertsons Merger Showdown
Mar 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Real Estate & Antitrust
Mar 27, 2024 by
CPI
Systematic National Evidence of Steering by Real Estate Agents
Mar 27, 2024 by
CPI
Compliance Now! Actionable Antitrust Advice for the Residential Real Estate Industry
Mar 27, 2024 by
CPI
Real Estate Commissions: Some Insights from the Economics of Multi-Sided Platforms
Mar 27, 2024 by
CPI
New Ideas for Promoting Real Estate Brokerage Price Competition
Mar 27, 2024 by
CPI